Followers | 373 |
Posts | 16807 |
Boards Moderated | 3 |
Alias Born | 03/07/2014 |
Friday, October 17, 2014 4:07:15 PM
Cash poor, debt laden and with a recent low common share price of about 1.5 cents today and just did a horrendous "finance" deal with a company called Magna for a grand total of about $200K in cash, but one that will result in probably 30 million plus shares in dilution.
They're so cash poor at any given time- that if one reads their 10-K/10-Q filing one will see literally, 10's of millions of shares of common stock being poured out, typically at a discount to market price, to pay everything from common bills like accounts payable to "interest owed" and vague entries to unknown parties such as, "for services rendered", etc
Nearly all key patents for their "flagship" "heart" product expired, a lien via Northstar giving them ownership over pretty much anything the company has or will have. They essentially license most of what they have as so called "technology" - meaning they don't even own it, nor did they invent it.
Endless dilution and use of convertible debt, toxic financing. Giving huge bonuses and raises to two insiders- when their entire medical R&D budget is running about $5K a month. (share count more than doubling in a single year period, now passing 600 million shares of common and 2 BILLION shares now authorized)
All major phase II/III trials they have stalled out for "lack of funding" according to their own SEC filings (Marvel, Mirror, Regen) despite handing out nearly a million in just "bonuses" to two people- not even counting their base salary pay increases.
Not even remotely close, as in years away, from any FDA approval of their major, once primary touted, product and focus, let alone no money to fund or finish those trials.
Now branching into some odd-ball (IMO) blend of off-shore, 2nd and 3rd world "medical tourism" using unproven, un-tested, non FDA approved so called "treatments" using stem cells??
I mean what am I missing here? What could possibly go wrong? Tell me what I'm missing I guess? What? Where?
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM